COMBINATION TREATMENT OF BACTERIAL INFECTION
The present invention resides in the discovery that combined use of kuraridin (or any one of its analogs) and epicatechin gallate (ECG) can provide heightened level of antimicrobial activity, especially for the suppression of bacteria of the Staphylococcus aureus and Staphylococcal species. Compositions, kits, and methods for the combination use are disclosed..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 21. Mai Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
IP MARGARET [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-05-21, Last update posted on www.tib.eu: 2024-01-02, Last updated: 2024-01-05 |
|---|
| Patentnummer: |
US2020155641 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004382234 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004382234 | ||
| 003 | DE-627 | ||
| 005 | 20240105084255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA004382234 | ||
| 035 | |a (EPA)US2020155641 | ||
| 035 | |a (EPA)70684386 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a IP MARGARET |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COMBINATION TREATMENT OF BACTERIAL INFECTION |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-05-21, Last update posted on www.tib.eu: 2024-01-02, Last updated: 2024-01-05 | ||
| 520 | |a The present invention resides in the discovery that combined use of kuraridin (or any one of its analogs) and epicatechin gallate (ECG) can provide heightened level of antimicrobial activity, especially for the suppression of bacteria of the Staphylococcus aureus and Staphylococcal species. Compositions, kits, and methods for the combination use are disclosed. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a FUNG KWOK PUI |4 aut | |
| 700 | 0 | |a LEUNG PING CHUNG |4 aut | |
| 700 | 0 | |a LAU CLARA BIK SAN |4 aut | |
| 700 | 0 | |a HAN QUAN BIN |4 aut | |
| 700 | 0 | |a CHAN CHUNG LAP |4 aut | |
| 700 | 0 | |a TSUI CHIT |4 aut | |
| 700 | 0 | |a WANG QUANDE |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 21. Mai |
| 773 | 1 | 8 | |g year:2020 |g day:21 |g month:05 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/70684386/publication/US2020155641A1?q=US2020155641 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2020 |b 21 |c 05 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 21 |c 05 | ||